News Daily News Free Spike Protein of mRNA COVID-19 Vaccines Implicated in Myocarditis Caitlin E. Cox January 11, 2023
News Daily News CV Risk After Acute COVID-19 Not So High as Feared: Registry Todd Neale January 06, 2023
News Conference News ESC 2022 COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19 Todd Neale September 01, 2022
News Daily News Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19 Todd Neale March 25, 2022
News Daily News Even Less-Severe COVID-19 Can Have Long-term CV Effects Caitlin E. Cox February 10, 2022
News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News ESC Releases Guidance on How to Address CVD in COVID-19 Era Yael L. Maxwell November 17, 2021
News Conference News TCT 2021 Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More Todd Neale November 04, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Daily News In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome Shelley Wood September 23, 2021
News Daily News Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report Michael O'Riordan April 16, 2021
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020
News Daily News More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California Shelley Wood May 22, 2020